Immunosuppressant Drugs

HEHS-94-207R: Published: Aug 1, 1994. Publicly Released: Aug 1, 1994.

Additional Materials:


Office of Public Affairs
(202) 512-4800

Pursuant to a congressional request, GAO provided information on the use of immunosuppressant drugs by organ transplant patients, focusing on: (1) the number of organ transplants performed in 1991; (2) the survival rates for the patients who receive immunosuppressant drugs; (3) the cost of extending Medicare coverage of immunosuppressant drugs; and (4) whether such drugs would be covered under the various health reform proposals. GAO noted that: (1) over 16,000 organ transplants were performed in 1991, and the number of transplants is increasing steadily; (2) the length of time that patients survive after a transplant has been increasing; (3) the cost of immunosuppressive therapy can range from $4,000 to $6,000 per person per year; (4) for beneficiaries who receive an organ transplant, Medicare currently pays for the necessary immunosuppressant drugs for the first year after the transplant operation; (5) the additional 2 years of Medicare coverage for immunosuppressant drugs would increase annual health care costs by $77 million; (6) extending coverage to 6 years would essentially double the costs to Medicare, adding approximately $115 million to the Medicare program; and (7) prescription drugs would be covered by the various health reform plans, but the Cooper/Breaux plan does not explicitly define the benefits to be provided.

Jul 21, 2017

Jul 20, 2017

Jul 19, 2017

Jul 18, 2017

Jul 17, 2017

Jul 11, 2017

Jun 30, 2017

Jun 26, 2017

May 30, 2017

Looking for more? Browse all our products here